Publicacions (80) Publicacions de MONICA GARCIA ALLOZA

2024

  1. Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes

    Neural Regeneration Research, Vol. 19, Núm. 6, pp. 1189-1190

  2. Glycogen Synthase Kinase-3β Inhibitor VP3.15 Ameliorates Neurogenesis, Neuronal Loss and Cognitive Impairment in a Model of Germinal Matrix-intraventricular Hemorrhage of the Preterm Newborn

    Translational Stroke Research

2023

  1. Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline

    Diabetologia, Vol. 66, Núm. 8, pp. 1557-1575

  2. Effect of caffeine in the intraventricular hemorrhage of the preterm newborn

    Neural Regeneration Research, Vol. 18, Núm. 9, pp. 1942-1943

  3. Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies

    Journal of neuroinflammation, Vol. 20, Núm. 1, pp. 57

  4. Rescue of neurogenesis and age-associated cognitive decline in SAMP8 mouse: Role of transforming growth factor-alpha

    Aging Cell, Vol. 22, Núm. 6

  5. Snacks de fisiología. Material audiovisual como herramienta de aprendizaje en fisiología humana

    Innovación docente y metodologías activas de enseñanza. Propuestas y resultados (Dykinson), pp. 507-524

2022

  1. Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

    Fluids and Barriers of the CNS, Vol. 19, Núm. 1

  2. Caffeine Restores Neuronal Damage and Inflammatory Response in a Model of Intraventricular Hemorrhage of the Preterm Newborn

    Frontiers in Cell and Developmental Biology, Vol. 10

  3. Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline

    Trends in Endocrinology and Metabolism, Vol. 33, Núm. 1, pp. 50-71

2021

  1. Alzheimer’s disease and diabetes: Role of diet, microbiota and inflammation in preclinical models

    Biomolecules, Vol. 11, Núm. 2, pp. 1-25

  2. Effects of classical PKC activation on hippocampal neurogenesis and cognitive performance: mechanism of action

    Neuropsychopharmacology, Vol. 46, Núm. 6, pp. 1207-1219

  3. Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer’s Disease and Type 2 Diabetes

    Frontiers in Aging Neuroscience, Vol. 13

  4. Mitochondria-ER contacts and glucose: the powerhouse of Alzheimer's disease?

    Cell Calcium

  5. Role of liraglutide in Alzheimer’s disease pathology

    Alzheimer's Research and Therapy, Vol. 13, Núm. 1

2020

  1. A novel PKC activating molecule promotes neuroblast differentiation and delivery of newborn neurons in brain injuries

    Cell Death and Disease, Vol. 11, Núm. 4

  2. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model

    Journal of Neuroinflammation, Vol. 17, Núm. 1

  3. Cell proliferation and neurogenesis alterations in Alzheimer’s disease and diabetes mellitus mixed murine models

    Journal of Neurochemistry, Vol. 154, Núm. 6, pp. 673-692

  4. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes

    Alzheimer's Research and Therapy, Vol. 12, Núm. 1

  5. Erythropoietin Improves Atrophy, Bleeding and Cognition in the Newborn Intraventricular Hemorrhage

    Frontiers in Cell and Developmental Biology, Vol. 8